United States - English - NLM (National Library of Medicine)

general injectables & vaccines, inc. - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of cefazolin for injection, usp and other antibacterial drugs, cefazolin for injection, usp should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. cefazolin for injection, usp is indicated for the treatment of the following serious infections due to susceptible organisms. 1.1 respiratory tract infections respiratory tract infections due to s. pneumoniae, klebsiella species, h. influenzae , s. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-hemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in treatment and prevention of strep

United States - English - NLM (National Library of Medicine)

sandoz gmbh - cefazolin sodium (unii: p380m0454z) (cefazolin - unii:ihs69l0y4t) - cefazolin for injection, usp is indicated in the treatment of the following serious infections due to susceptible organisms: respiratory tract infections: due to s. pneumoniae, klebsiella species, h. influenzae, s. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-hemolytic streptococci. injectable benzathine penicillin is considered to be the drug of choice in treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. cefazolin for injection, usp is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present. urinary tract infections: due to e. coli, p. mirabilis, klebsiella species, and some strains of enterobacter and enterococci. skin and skin structure infections: due to s. aureus (penicillin-sensitive and penicillin-resistant), group a beta-hemolytic streptococci, and other strains of streptococci.

Canada - English - Health Canada

sterimax inc - cefazolin (cefazolin sodium) - powder for solution - 2g - cefazolin (cefazolin sodium) 2g

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noridem enterprises ltd. - cefazolin sodium 1,048 g - eq. cefazolin 1 g - powder for solution for injection/infusion - 1 g - cefazolin sodium 1.048 g - cefazolin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noridem enterprises ltd. - cefazolin sodium 2,096 g - eq. cefazolin 2 g - powder for solution for injection/infusion - 2 g - cefazolin sodium 2.096 g - cefazolin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - cefazolin sodium 1048 mg - eq. cefazolin 1000 mg - powder for solution for injection - 1 g - cefazolin sodium 1048 mg - cefazolin

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - cefazolin sodium 2096 mg - eq. cefazolin 2000 mg - powder for solution for injection - 2 g - cefazolin sodium 2096 mg - cefazolin

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - cefazolin sodium 1.048 g equivalent cefazolin 1 g;   - injection with diluent - 1 g - active: cefazolin sodium 1.048 g equivalent cefazolin 1 g   excipient: water for injection

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - cefazolin sodium 524mg equivalent to cefazolin 500 mg;   - injection with diluent - 500 mg - active: cefazolin sodium 524mg equivalent to cefazolin 500 mg   excipient: water for injection

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - cefazolin sodium, quantity: 2096 mg - injection, powder for - excipient ingredients: - cefazolin is indicated in the treatment of the following serious infections due to susceptible organisms:,respiratory tract infections due to s. pneumoniae, klebsiella species, h. influenzae, staph. aureus (penicillin-sensitive and penicillin- resistant), and group a beta-haemolytic streptococci.,injectable benzathine penicillin is considered to be the drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever.,cefazolin is effective in the eradication of streptococci from the nasopharynx; however, data establishing the efficacy of cefazolin in the subsequent prevention of rheumatic fever are not available at present.,genitourinary tract infections due to esch. coli, pr. mirabilis, klebsiella species, and some strains of enterobacter and enterococci.,skin and skin structure infections due to staph. aureus (penicillin-sensitive and penicillin- resistant), and group a beta-haemolytic streptococci and other strains of streptococci.,bone and joint infections due to staph. aureus.,septicaemia due to s. pneumoniae, staph. aureus (penicillin-sensitive and penicillin-resistant), pr. mirabilis, esch. coli and klebsiella species.,endocarditis due to staph. aureus (penicillin-sensitive and penicillin-resistant), and group a beta-haemolytic streptococci.,appropriate culture and susceptibility studies should be performed to determine susceptibility of the causative organism to cefazolin.